GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHY) » Definitions » Cyclically Adjusted Price-to-FCF

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Cyclically Adjusted Price-to-FCF : 30.29 (As of Apr. 29, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Santen Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

As of today (2024-04-29), Santen Pharmaceutical Co's current share price is $9.39. Santen Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $0.31. Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is 30.29.

The historical rank and industry rank for Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SNPHY' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 29.98   Med: 48.58   Max: 70.38
Current: 34.16

During the past years, Santen Pharmaceutical Co's highest Cyclically Adjusted Price-to-FCF was 70.38. The lowest was 29.98. And the median was 48.58.

SNPHY's Cyclically Adjusted Price-to-FCF is ranked worse than
50.15% of 325 companies
in the Drug Manufacturers industry
Industry Median: 32.81 vs SNPHY: 34.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Santen Pharmaceutical Co's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.589. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.31 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Santen Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Santen Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.96 53.96 45.22 39.08 34.13

Santen Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.79 34.13 37.35 37.25 31.73

Competitive Comparison of Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Santen Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=9.39/0.31
=30.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Santen Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.589/106.8000*106.8000
=0.589

Current CPI (Dec. 2023) = 106.8000.

Santen Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.251 95.700 0.280
201406 -0.134 98.000 -0.146
201409 -1.097 98.500 -1.189
201412 0.078 97.900 0.085
201503 0.192 97.900 0.209
201506 -0.056 98.400 -0.061
201509 0.228 98.500 0.247
201512 0.082 98.100 0.089
201603 0.016 97.900 0.017
201606 -0.417 98.100 -0.454
201609 0.198 98.000 0.216
201612 0.073 98.400 0.079
201703 0.169 98.100 0.184
201706 0.086 98.500 0.093
201709 0.307 98.800 0.332
201712 0.103 99.400 0.111
201803 0.240 99.200 0.258
201806 -0.106 99.200 -0.114
201809 0.402 99.900 0.430
201812 0.053 99.700 0.057
201903 0.189 99.700 0.202
201906 0.067 99.800 0.072
201909 0.378 100.100 0.403
201912 0.029 100.500 0.031
202003 0.239 100.300 0.254
202006 -0.021 99.900 -0.022
202009 0.149 99.900 0.159
202012 -0.060 99.300 -0.065
202103 0.278 99.900 0.297
202106 -0.050 99.500 -0.054
202109 0.335 100.100 0.357
202112 -0.042 100.100 -0.045
202203 -0.010 101.100 -0.011
202206 -0.072 101.800 -0.076
202209 0.115 103.100 0.119
202212 0.104 104.100 0.107
202303 0.094 104.400 0.096
202306 -0.007 105.200 -0.007
202309 0.429 106.200 0.431
202312 0.589 106.800 0.589

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Santen Pharmaceutical Co  (OTCPK:SNPHY) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Santen Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Santen Pharmaceutical Co (Santen Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Headlines

From GuruFocus

Matthews Japan Fund 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 04-23-2020

Matthews Japan Fund Comments on Santen Pharmaceutical

By Sydnee Gatewood Sydnee Gatewood 04-23-2020